Anti‐inflammatory effects of exendin‐4, a glucagon‐like peptide‐1 analog, on human peripheral lymphocytes in patients with type 2 diabetes

AIMS/INTRODUCTION: Type 2 diabetes is characterized by dysregulation of immunity, oxidative stress and reduced incretin effects. Experimental studies suggest that glucagon‐like peptide (GLP‐1) might have immunomodulating effects. We hypothesize that GLP‐1 receptor agonist, exendin‐4, might reduce in...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lan, Wong, Chun Kwok, Cheung, Kitty KT, Yau, Ho Chung, Fu, Anthony, Zhao, Hai‐lu, Leung, Karen ML, Kong, Alice PS, Wong, Gary WK, Chan, Paul KS, Xu, Gang, Chan, Juliana CN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020234/
https://www.ncbi.nlm.nih.gov/pubmed/24843684
http://dx.doi.org/10.1111/jdi.12063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020234/
https://www.ncbi.nlm.nih.gov/pubmed/24843684
http://dx.doi.org/10.1111/jdi.12063

Ejemplares similares